市場調査レポート

商品コード

1413347

希少疾患診断市場：コンポーネント、技術、疾患タイプ、最終用途別-世界予測、2024～2030年

Rare Disease Diagnostics Market by Component (Consumable & Assay Kit, Diagnostic Instrument), Technology (Array Technology, Next Generation Sequencing, Sanger Sequencing), Disease Type, End-use - Global Forecast 2024-2030

出版日: 2024年01月15日 | 発行: 360iResearch

| ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 744,453円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 901,213円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,057,973円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,371,493円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

希少疾患診断市場規模は2023年に26億8,000万米ドルと推定され、2024年には31億2,000万米ドルに達し、CAGR 17.36%で2030年には82億3,000万米ドルに達すると予測されます。

希少疾患診断の世界市場

主要市場の統計
基準年[2023年]	26億8,000万米ドル
予測年[2024年]	31億2,000万米ドル
予測年[2030年]	82億3,000万米ドル
CAGR（%）	17.36%

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは希少疾患診断市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます。フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、希少疾患診断市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発とイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-希少疾患診断市場の市場規模と予測は？

2-希少疾患診断市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-希少疾患診断市場における技術動向と規制の枠組みは？

4-希少疾患診断市場における主要ベンダーの市場シェアは？

5-希少疾患診断市場への参入に適した形態や戦略的手段は？

市場力学
- 促進要因
  - 希少な遺伝性疾患の蔓延と早期かつ迅速な診断の必要性
  - トランスレーショナル研究とゲノム調査における新規変異の同定のための使用の増加
  - 希少疾患の診断と治療に対する政府の取り組み
- 抑制要因
  - 新しい希少疾患の遺伝子検査の承認プロセスに関連する厳しい規制
- 機会
  - 新たな希少疾患遺伝子を特定するための遺伝子技術の進歩
  - 希少遺伝性疾患の診断に対する有利な投資
- 課題
  - 倫理的懸念と希少疾患に関する限られた情報へのアクセス
市場セグメンテーション分析
市場動向分析
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み

第6章希少疾患診断市場：コンポーネント別

イントロダクション
消耗品とアッセイキット
診断機器

第7章希少疾患診断市場：技術別

イントロダクション
アレイ技術
次世代シーケンス
サンガー配列決定

第8章希少疾患診断市場：疾患タイプ別

イントロダクション
がん
心血管疾患
皮膚科疾患
内分泌・代謝疾患
血液疾患
免疫疾患
筋骨格系疾患
神経学的障害

第9章希少疾患診断市場：最終用途別

イントロダクション
診断ラボ
病院とクリニック
研究とCRO

第10章南北アメリカの希少疾患診断市場

イントロダクション
アルゼンチン
ブラジル
カナダ
メキシコ
米国

第11章アジア太平洋の希少疾患診断市場

イントロダクション
オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第12章欧州・中東・アフリカの希少疾患診断市場

イントロダクション
デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第13章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ主要企業別の分析

第14章競合ポートフォリオ

主要な企業プロファイル
- 23andMe Inc.
- 3billion, Inc.
- Agilent Technologies Inc.
- ARCHIMED Life Science GmbH
- ARUP Laboratories
- AstraZeneca PLC
- Azenta Life Sciences
- Baylor Genetics
- Caris Life Sciences
- CENTOGENE N.V.
- Eurofins Scientific Inc.
- F. Hoffmann-La Roche Ltd.
- Fulgent Genetics, Inc.
- Illumina, Inc.
- In-Depth Genomics
- Invitae Corporation
- Laboratory Corporation of America Holdings
- MedGenome Labs Ltd
- OPKO Health, Inc.
- PerkinElmer Inc.
- Progenity, Inc.
- Quest Diagnostics Incorporated
- Sanofi S.A.
- Thermo Fisher Scientific Inc.
- Travere Therapeutics Inc.
主要な製品ポートフォリオ

第15章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. RARE DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. RARE DISEASE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. RARE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RARE DISEASE DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 8. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 12. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 14. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. RARE DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. RARE DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

TABLE 1. RARE DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. RARE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 6. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLE & ASSAY KIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 9. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY ARRAY TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 13. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DERMATOLOGY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY ENDOCRINE & METABOLISM DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 22. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES & CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 38. CANADA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 39. CANADA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. CANADA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 42. MEXICO RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 43. MEXICO RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. MEXICO RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. CHINA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 61. CHINA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. CHINA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 63. CHINA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 64. INDIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 65. INDIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. INDIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. JAPAN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 73. JAPAN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. JAPAN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 75. JAPAN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 96. THAILAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 97. THAILAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. THAILAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 99. THAILAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. DENMARK RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 110. DENMARK RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. DENMARK RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 113. EGYPT RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 114. EGYPT RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. EGYPT RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 116. EGYPT RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. FINLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 118. FINLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. FINLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 120. FINLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 121. FRANCE RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 122. FRANCE RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. FRANCE RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 126. GERMANY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. GERMANY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 133. ITALY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 134. ITALY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. ITALY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 136. ITALY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. NORWAY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 146. NORWAY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. NORWAY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 148. NORWAY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 149. POLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 150. POLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. POLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 152. POLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 153. QATAR RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 154. QATAR RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. QATAR RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 156. QATAR RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 170. SPAIN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. SPAIN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 172. SPAIN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 181. TURKEY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 182. TURKEY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. TURKEY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 184. TURKEY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 193. RARE DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 194. RARE DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 195. RARE DISEASE DIAGNOSTICS MARKET LICENSE & PRICING

Product Code: MRR-5C6F41F5B05A

[184 Pages Report] The Rare Disease Diagnostics Market size was estimated at USD 2.68 billion in 2023 and expected to reach USD 3.12 billion in 2024, at a CAGR 17.36% to reach USD 8.23 billion by 2030.

Global Rare Disease Diagnostics Market

KEY MARKET STATISTICS
Base Year [2023]	USD 2.68 billion
Estimated Year [2024]	USD 3.12 billion
Forecast Year [2030]	USD 8.23 billion
CAGR (%)	17.36%

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Rare Disease Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Rare Disease Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Rare Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 23andMe Inc., 3billion, Inc., Agilent Technologies Inc., ARCHIMED Life Science GmbH, ARUP Laboratories, AstraZeneca PLC, Azenta Life Sciences, Baylor Genetics, Caris Life Sciences, CENTOGENE N.V., Eurofins Scientific Inc., F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., Illumina, Inc., In-Depth Genomics, Invitae Corporation, Laboratory Corporation of America Holdings, MedGenome Labs Ltd, OPKO Health, Inc., PerkinElmer Inc., Progenity, Inc., Quest Diagnostics Incorporated, Sanofi S.A., Thermo Fisher Scientific Inc., and Travere Therapeutics Inc..

Market Segmentation & Coverage

This research report categorizes the Rare Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Component
- Consumable & Assay Kit
- Diagnostic Instrument
Technology
- Array Technology
- Next Generation Sequencing
- Sanger Sequencing
Disease Type
- Cancer
- Cardiovascular Disorders
- Dermatology Disease
- Endocrine & Metabolism Diseases
- Hematology Diseases
- Immunological Disorders
- Musculoskeletal Disorders
- Neurological Disorders
End-use
- Diagnostic Laboratories
- Hospitals & Clinics
- Research Laboratories & CROs
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Rare Disease Diagnostics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Rare Disease Diagnostics Market?

3. What are the technology trends and regulatory frameworks in the Rare Disease Diagnostics Market?

4. What is the market share of the leading vendors in the Rare Disease Diagnostics Market?

5. Which modes and strategic moves are suitable for entering the Rare Disease Diagnostics Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Rare Disease Diagnostics Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing prevalence of rare genetic diseases and the need for early & rapid diagnosis
  - 5.1.1.2. Rising use in translational & genomic research for the identification of novel mutations
  - 5.1.1.3. Government initiatives for diagnosis and treatment of rare diseases
- 5.1.2. Restraints
  - 5.1.2.1. Stringent regulations associated with the approval process of new rare diseases genetic test
- 5.1.3. Opportunities
  - 5.1.3.1. Advancements in genetic technology to Identify new rare disease genes
  - 5.1.3.2. Favorable investments for diagnosis of rare genetic diseases
- 5.1.4. Challenges
  - 5.1.4.1. Ethical concerns and access to limited information on rare disease
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Rare Disease Diagnostics Market, by Component

6.1. Introduction
6.2. Consumable & Assay Kit
6.3. Diagnostic Instrument

7. Rare Disease Diagnostics Market, by Technology

7.1. Introduction
7.2. Array Technology
7.3. Next Generation Sequencing
7.4. Sanger Sequencing

8. Rare Disease Diagnostics Market, by Disease Type

8.1. Introduction
8.2. Cancer
8.3. Cardiovascular Disorders
8.4. Dermatology Disease
8.5. Endocrine & Metabolism Diseases
8.6. Hematology Diseases
8.7. Immunological Disorders
8.8. Musculoskeletal Disorders
8.9. Neurological Disorders

9. Rare Disease Diagnostics Market, by End-use

9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Hospitals & Clinics
9.4. Research Laboratories & CROs

10. Americas Rare Disease Diagnostics Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Rare Disease Diagnostics Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Rare Disease Diagnostics Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
- 14.1.1. 23andMe Inc.
- 14.1.2. 3billion, Inc.
- 14.1.3. Agilent Technologies Inc.
- 14.1.4. ARCHIMED Life Science GmbH
- 14.1.5. ARUP Laboratories
- 14.1.6. AstraZeneca PLC
- 14.1.7. Azenta Life Sciences
- 14.1.8. Baylor Genetics
- 14.1.9. Caris Life Sciences
- 14.1.10. CENTOGENE N.V.
- 14.1.11. Eurofins Scientific Inc.
- 14.1.12. F. Hoffmann-La Roche Ltd.
- 14.1.13. Fulgent Genetics, Inc.
- 14.1.14. Illumina, Inc.
- 14.1.15. In-Depth Genomics
- 14.1.16. Invitae Corporation
- 14.1.17. Laboratory Corporation of America Holdings
- 14.1.18. MedGenome Labs Ltd
- 14.1.19. OPKO Health, Inc.
- 14.1.20. PerkinElmer Inc.
- 14.1.21. Progenity, Inc.
- 14.1.22. Quest Diagnostics Incorporated
- 14.1.23. Sanofi S.A.
- 14.1.24. Thermo Fisher Scientific Inc.
- 14.1.25. Travere Therapeutics Inc.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

希少疾患診断市場：コンポーネント、技術、疾患タイプ、最終用途別-世界予測、2024～2030年

Rare Disease Diagnostics Market by Component (Consumable & Assay Kit, Diagnostic Instrument), Technology (Array Technology, Next Generation Sequencing, Sanger Sequencing), Disease Type, End-use - Global Forecast 2024-2030

本レポートは、以下の側面に関する貴重な洞察を提供しています：

本レポートは、以下のような主要な質問に対応しています：

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

第6章 希少疾患診断市場：コンポーネント別

第7章 希少疾患診断市場：技術別

第8章 希少疾患診断市場：疾患タイプ別

第9章 希少疾患診断市場：最終用途別

第10章 南北アメリカの希少疾患診断市場

第11章 アジア太平洋の希少疾患診断市場

第12章 欧州・中東・アフリカの希少疾患診断市場

第13章 競合情勢

第14章 競合ポートフォリオ

第15章 付録